cdmo.directory
← Home
Ascend logo

Ascend

Gene-to-GMP development partner for advanced biologics, vaccines, and gene therapies.

Ascend is a gene-to-GMP development partner specializing in advanced biologics and vaccines with 60+ years of custom biologics expertise and 20+ years of AAV development capability. The company offers onsite fill-finish capabilities across multiple US locations and combines next-generation technologies with deep regulatory acumen.

Modalities

Development & manufacturing

Structured CDMO capabilities from verified public sources.

Manufacturing (M)

Biologics / bioreactor infrastructure

Expression systems
Viral Vector

Fill-finish formats

Regulatory clearances

Services

Indications

About this organization

Ascend supports development and manufacturing of gene therapies, immunotherapies, oncolytics, and vaccines at any scale. The company brings 60+ years of custom biologics and vaccines experience combined with 20+ years of specialized AAV development expertise.

Key Capabilities:

  • Gene-to-GMP development partnership model
  • AAV vector development and manufacturing
  • Onsite fill-finish capabilities in multiple US locations
  • Next-generation technologies and analytics
  • Deep regulatory expertise for advanced therapy products

Ascend positions itself as a collaborative partner supporting life-science innovators from bench through clinic and beyond, with a philosophy emphasizing higher yields, purity, assay sensitivity, and batch throughput.

Related companies

Similar profiles by shared services, modalities, and capabilities.

Submit a verified review for this organization.

Markdown mirror: /companies/ascend-adv.md